Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with least two asthma diagnosis
Patients will be required to be concurrently on inhaled corticosteroids (ICS)+Tiotropium (tio) (specifically Tiotropium Respimat® 1.25 mcg) or ICS/LABA
Patients will be required to have enrollment for at least 6 months prior to ICS+Tio or ICS/LABA use
You may not be if
Patients with least two diagnosis of chronic obstructive pulmonary disease (COPD) at any time during the study period
Patients less than 12 years of age
Patients on biologics within 6 months prior to ICS+Tio or ICS/LABA use
Patients with prior Tio or ICS/LABA use during the 6-month baseline period
Patients with urinary bladder obstruction, urinary retention, and glaucoma
After the propensity score matching (PSM) process, unmatched patients
